Hôpital de la Conception

Running trials

• Not yet recruiting

  Development of an Aid to Melanoma Detection Using Artificial Intelligence Algorithms Based on Images From the VECTRA 3D System.

  NCT06999499· Assistance Publique Hopitaux De Marseille· Source

• Not yet recruiting

  ActiTENS Mini (Transcutaneous Electrical Stimulation) in Women With Chronic Pain From Pelvic Endometriosis

  NCT07317037· Assistance Publique - Hôpitaux de Paris· Source

• Not yet recruiting

  Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Donor: Results of Kidney Transplantations Performed in Accordance to the French Guidelines.

  NCT07379957· University Hospital, Bordeaux· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

  NCT07137598· Phase 2· Hoffmann-La Roche· Source

• Recruiting

  Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)

  NCT06960902· Nantes University Hospital· Source

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Amgen· Source

• Recruiting

  A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

  NCT06570798· Phase 2· Amgen· Source

• Active, not recruiting

  A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

  NCT06962280· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

  NCT06914895· Phase 3· Eli Lilly and Company· Source

• Recruiting

  EWALL-PH OBSERVARTORY 2022

  NCT07684131· Versailles Hospital· Source

• Recruiting

  A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

  NCT06091254· Phase 3· Regeneron Pharmaceuticals· Source

• Recruiting

  Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment

  NCT05580861· Phase 1/2· Assistance Publique - Hôpitaux de Paris· Source

• Recruiting

  Rheopheresis as Adjuvant Treatment of Calciphylaxis

  NCT04654000· University Hospital, Lille· Source

• Active, not recruiting

  Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome

  NCT05382156· RECORDATI GROUP· Source

• Recruiting

  Involvement of CDA and/or dCK Metabolizing Enzymes in the Response to Azacytidine Treatment of Patients With Hematologic Malignancies

  NCT06886425· Assistance Publique Hopitaux De Marseille· Source

• Active, not recruiting

  A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)

  NCT04628494· Phase 3· Genmab· Source

• Recruiting

  A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort

  NCT03755726· Centre Hospitalier de PAU· Source

• Active, not recruiting

  International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer

  NCT03386734· Centre Hospitalier Universitaire de Besancon· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia2 recruiting
• Chronic kidney disease2 recruiting
• Rheumatoid arthritis2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Coronary artery disease1 recruiting
• Endometriosis1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Follicular lymphoma1 recruiting
• High blood pressure1 recruiting
• Lupus (SLE)1 recruiting
• Melanoma1 recruiting
• Myelodysplastic syndromes1 recruiting

Closed trials

• Completed

  Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven

  NCT06030089· Centre Hospitalier Universitaire de Nice· Source

• Completed

  DBLG1 System With TERUMO MEDISAFE WITH Insulin Pump Trial

  NCT05628532· Diabeloop· Source

• Completed

  Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)

  NCT05489120· Dr. Schär AG / SPA· Source

• Completed

  Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE

  NCT05001737· Phase 3· Swedish Orphan Biovitrum· Source

• Withdrawn

  A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)

  NCT04264806· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  Study Venetoclax Effectiveness and Real-Life Treatment Management in Participants With Chronic Lymphocytic Leukemia

  NCT03415035· AbbVie· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Cushing's syndrome7 works · 1 trial
• Fabry disease3 works · 0 trials